Company / SG&A per Share
Immunocore Holdings plc SG&A per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$3.30
FY2025
5-year range
$2.61 / $3.30
FY2021-FY2025
Trend
+5.5%
vs FY2024
Sector context
#55 of 210
Health Care
What the data says
At $3.30, Immunocore Holdings plc's sg&a per share ranks #156 of 210 in the Health Care sector. SG&A per Share has increased for 4 consecutive years, from $2.61 in FY2021 to $3.30 in FY2025.
Based on SEC 10-K filings.
3.30 in FY2025 with a 3-year CAGR of +7.1%.
Increased from $3.00 to $3.30 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +7.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#156 of 210 in Health CareTop 74% of 210This company $3.30 Sector average $40.75
▼
-91.9% below sector average
Key checks
Key Insights
- Immunocore Holdings plc's sg&a per share has grown for 4 consecutive years.
- In FY2025, sg&a per share increased 5.5% year-over-year.
- Ranks #55 out of 210 companies in the Health Care sector.
- Lowest sg&a per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.32 (distress zone, below 1.8 threshold)
- Negative profit margin: -16.5%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.30 | +5.5% |
| FY2024 | $3.13 | +4.3% |
| FY2023 | $3.00 | +11.6% |
| FY2022 | $2.69 | +3.2% |
| FY2021 | $2.61 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026